Reshaped by COVID-19, rising test demand, and a shift toward decentralized diagnostics, qPCR has evolved from niche academic use to a core clinical engine
Gambhir brings over 35 years of rich experience in strategic finance, governance, business transformation, and leadership
Market authorization for generic GLP-1 therapy strengthens company’s diabetes portfolio in Canada
The deal, backed by healthcare investor ARCHIMED, signals a major push to accelerate connected, patient-centered cardiac care worldwide
With the convergence of AI, robotics, and neuroscience, Motorica is advancing toward more intuitive, intent-driven prosthetic systems
The partnership integrates BD’s ZebraSci, a device-agnostic testing platform, with Suttons Creek’s expertise in combination product development and systems integration
The association is intended to strengthen healthcare delivery standards, particularly in Oncology services, and enhance patient care outcomes
The agreement could rise to $900 million if key commercial milestones are met
Company to highlight science-backed actives, nature-powered ingredients, and its new “Natural by Barentz” private label platform in Barcelona
Acquisition enhances integrated pharmacovigilance platform, combining AI, automation, and services to improve compliance, efficiency, and end-to-end clinical safety operations
Subscribe To Our Newsletter & Stay Updated
